 |
2-[(3-methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)methylsulfinyl] -1H-benzoimidazole |
|---|---|
| Trade Name | Prevonco (Tm) |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2008-08-27 00:00:00 |
| Sponsor | BioQuant, Inc.;6330 Nancy Ridge Drive;San Diego, California, 92121 |
